Oppenheimer Upgrades Incyte to Outperform, Raises Target to $144
Oppenheimer raised its price target from $120 to $144. The new target implies 23.3% upside from Incyte's Oct. 29 close of $116.80.
Oppenheimer raised its price target from $120 to $144. The new target implies 23.3% upside from Incyte's Oct. 29 close of $116.80.